Arkolith/Insider Trading/NMRA/Form 4

ARCH Venture Partners VIII, LLC

10% OwnerNeumora Therapeutics, Inc. (NMRA) · full profile →Form 4 · filed Oct 29, 2025
Net Buying
Open-Market Buys
$5.0M
Open-Market Sells
$0
Net Open-Market Flow
$5.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 27, 2025Buy(P)1.9M$2.61$5.0M6.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001012975-25-000679) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML